logo

FRESENIUS(NYSE:FMS)
Fresenius Medical Care provides a range of products for both treatment modalities, hemmodialysis and peritoneal dialysis, and is a full service provider of dialysis care. They provide dialysis treatment and related laboratory and diagnostic services at more than 1,000 dialysis clinics. They manufacture a range of hemodialysis machines, dialyzers, peritoneal dialysis solutions and ancillary products. They have operations in approximately 100 countries.
# Employees: 37331
Address: ELSE-KRONER STRASSE 1,BAD HOMBURG,,DEU
Phone: 6172 609-2525
Fax: 6172 609-2301
Website: www.fmc-ag.com
Email: ir-fmcna@fmc-ag.com
Sector: Medical
Industry: MED INSTRUMENTS
Executive Officers
Ben J. Lipps (Pres.; Dir.)
Jerry A. Schneider (C.F.O.; Tres.; Dir.)
Dividend
Ex-Dividend Date: 1/1/1990
Annual Dividend: $0.56
Current Dividend Yield: $1.05
Dividend Paid (3 months): $0.00
Indicated Dividend: $0.19
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 2/18/2010
Mean EPS (Next Qtr): $0.79
Mean EPS (Year): $2.95
Mean Estimate(Long Term): $11.25
P/E Ratio(Based on EPS estimate): 18.070
Number of Estimates: 8
Shares Performance
Period FMS Compare to S&P
YTD 12.99 % -6.49 %
4 Weeks 10.24 % 4.65 %
12 Weeks 22.13 % 13.73 %
Shares Information
Analyst Coverage: Y
Avg Volume: 68546
Shares Outstanding: 292M
Market Cap: $15.61B
52 Week High: $54.29
52 Week Low: $35.66
P/E Ratio: 18.380
PEG Ratio: 1.610
Split: On 1/1/1990 FMS split by factor of 0.010
Earnings Performance
EPS Growth in Last Quarter: 2.70 %
EPS Growth in Last Year: 10.14 %
Sales Growth in Last Quarter: 4.53 %
Sales Growth in Last Quarter: 6.46 %
Financials
Qtr Book Value: $2.51
Cash Flow/Share: $12.66
Change in Payout Ratio: -0.030
Price/Sales: 1.430
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia